Moderna swung to profit and raised its revenue growth forecast to 15% to 25%
Summary
Third-quarter revenue rose 29% from a year earlier as international COVID vaccine sales climbed; the prior outlook was up to 10% growth
Description from Quartz.
Who is covering this
-
Moderna swung to profit and raised its revenue growth forecast to 15% to 25%
Third-quarter revenue rose 29% from a year earlier as international COVID vaccine sales climbed; the prior outlook was up to 10% growth
Video coverage
Comments
Comments need JavaScript.